Autonomix Medical Announces Results From Preclinical Study Demonstrating Ability Of Its Neural Sensing Platform To Detect, Localize And Confirm Changes In Renal Neural Activity
The study successfully demonstrated Autonomix's ability to identify neural signals associated with nerve activity along the renal artery and surrounding tissue, providing direct physiological feedback before and
Autonomix showed in early lab testing that its device can detect nerve signals in the kidney area, which is a step toward helping doctors understand kidney problems better. This is an early win, but the company still needs to prove the device works safely and helps real patients before doctors can use it.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.